Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “sell” rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating […]

Leave a Reply

Your email address will not be published.

Previous post Twist Bioscience (NASDAQ:TWST) Price Target Raised to $65.00
Next post Wendy’s’ (WEN) Hold Rating Reiterated at TD Cowen